MX2021007667A - Composiciones y metodos para detectar un contaminante biologico. - Google Patents

Composiciones y metodos para detectar un contaminante biologico.

Info

Publication number
MX2021007667A
MX2021007667A MX2021007667A MX2021007667A MX2021007667A MX 2021007667 A MX2021007667 A MX 2021007667A MX 2021007667 A MX2021007667 A MX 2021007667A MX 2021007667 A MX2021007667 A MX 2021007667A MX 2021007667 A MX2021007667 A MX 2021007667A
Authority
MX
Mexico
Prior art keywords
compositions
methods
detecting
biological contaminant
rapid
Prior art date
Application number
MX2021007667A
Other languages
English (en)
Inventor
Serge Monpoeho
Sheldon Mink
Paul VESCIO
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56297073&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2021007667(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2021007667A publication Critical patent/MX2021007667A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

En la presente, se proporcionan composiciones y métodos útiles para determinar si un contaminante microbiano está presente en un proceso de producción terapéutico biológico. Específicamente, se proporcionan un plásmido de control de amplificación positivo artificial y una sonda para detección de PCR cuantitativa única, lo cual permite una detección rápida y en tiempo real de un resultado falso positivo.
MX2021007667A 2015-03-27 2017-09-27 Composiciones y metodos para detectar un contaminante biologico. MX2021007667A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562139321P 2015-03-27 2015-03-27

Publications (1)

Publication Number Publication Date
MX2021007667A true MX2021007667A (es) 2021-08-05

Family

ID=56297073

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017012437A MX2017012437A (es) 2015-03-27 2016-03-25 Composiciones y metodos para detectar un contaminante biologico.
MX2021007667A MX2021007667A (es) 2015-03-27 2017-09-27 Composiciones y metodos para detectar un contaminante biologico.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017012437A MX2017012437A (es) 2015-03-27 2016-03-25 Composiciones y metodos para detectar un contaminante biologico.

Country Status (20)

Country Link
US (3) US10669594B2 (es)
EP (3) EP3274469B1 (es)
JP (4) JP6670847B2 (es)
KR (2) KR20240063188A (es)
CN (2) CN114875175A (es)
AR (2) AR104110A1 (es)
AU (2) AU2016243498B2 (es)
BR (1) BR112017020582A2 (es)
CA (2) CA3226784A1 (es)
DK (1) DK3274469T3 (es)
EA (2) EA037740B1 (es)
ES (1) ES2804845T3 (es)
IL (4) IL302434A (es)
MX (2) MX2017012437A (es)
PL (1) PL3274469T3 (es)
PT (1) PT3274469T (es)
SG (2) SG11201707690QA (es)
TW (3) TW202336236A (es)
WO (1) WO2016160572A1 (es)
ZA (2) ZA201706797B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202336236A (zh) 2015-03-27 2023-09-16 美商再生元醫藥公司 偵測生物污染物之組成物及方法
US11248054B2 (en) 2017-06-12 2022-02-15 Bluefin Biomedicine, Inc. Anti-IL1RAP antibodies and antibody drug conjugates
US20190093149A1 (en) * 2017-09-27 2019-03-28 The United States Of America, As Represented By The Secretary Of Agriculture Assays for detecting multiple tick-borne pathogens
EP3746565A4 (en) * 2018-01-30 2021-11-03 BioFire Defense, LLC METHODS AND SYSTEMS FOR VALIDATION OF A NUCLEIC ACID AMPLIFICATION ASSAY
RU2020130821A (ru) * 2018-03-20 2022-04-20 ЛУМАСАЙТ, ЭлЭлСи Улучшенный биофизический и биохимический клеточный мониторинг и количественный анализ с использованием цитологии на основе силы лазера
US11702653B2 (en) 2018-05-21 2023-07-18 Battelle Memorial Institute Control compositions and methods for sequencing
US11441176B2 (en) 2018-12-13 2022-09-13 Battelle Memorial Institute Methods and control compositions for a quantitative polymerase chain reaction
KR102278112B1 (ko) * 2020-07-10 2021-07-15 (주)하임바이오텍 특정 인공 뉴클레오타이드 서열을 이용한 위양성 판단용 조성물 및 이를 이용한 위양성 판단 방법
KR102532614B1 (ko) * 2020-09-18 2023-05-16 한국식품연구원 가공식품 및 농산물의 설치류 오염여부를 판별하는 방법
CA3205130A1 (en) * 2020-12-17 2022-06-23 Amgen Inc. Real time pcr method to detect bovine parvovirus 3
KR20230011040A (ko) * 2021-07-13 2023-01-20 재단법인 바이오나노헬스가드연구단 미생물 현장 오염 검출용 조성물 및 이의 용도
CN114561492A (zh) * 2022-02-28 2022-05-31 宁夏回族自治区疾病预防控制中心(宁夏回族自治区性病艾滋病防治中心) 一种新冠病毒核酸检测阳性质控品及其制备方法和用途
CN116814848B (zh) * 2023-04-12 2024-03-19 中国医学科学院医学实验动物研究所 基于荧光raa检测小鼠微小病毒的引物和探针及方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5585254A (en) * 1987-08-21 1996-12-17 University Of Colorado Foundation, Inc. Autonomous parvovirus gene delivery vehicles and expression vectors
US5371241A (en) 1991-07-19 1994-12-06 Pharmacia P-L Biochemicals Inc. Fluorescein labelled phosphoramidites
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
DE69942200D1 (de) 1999-08-13 2010-05-12 Deutsches Krebsforsch Parvovirus NS1 Varianten
AT409383B (de) 1999-12-22 2002-07-25 Baxter Ag Verfahren zur detektion und quantifizierung von nukleinsäuren in einer probe
US20020177222A1 (en) * 2000-08-10 2002-11-28 Sikun Li Replication competent AAV helper functions
KR100888377B1 (ko) * 2001-06-28 2009-03-13 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 파르보바이러스 ｂ19의 진단 분석
CN1302337C (zh) 2002-03-08 2007-02-28 Asml荷兰有限公司 光刻投射设备、所用的反射掩模以及器件制作方法
JP2006505275A (ja) 2002-11-12 2006-02-16 ジェノライフ 工業製品において微生物を普遍的に検出するための一段階リアルタイムｒｔ−ｐｃｒキット
WO2004104229A2 (en) * 2003-05-16 2004-12-02 Vickery Michael C L Internal control nucleic acid molecule for nucleic acid amplification systems
DE102006034844B3 (de) * 2006-07-27 2007-12-06 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Zusammensetzungen und Verfahren zur Amplifikation von Hepatitis A-Viren (HAV) und/oder Parvoviren B19 (PB19) mittels Multiplex-PCR
PL2150617T3 (pl) 2007-06-04 2015-04-30 Regeneron Pharma Wzmocniona ekspresja i regiony stabilności
EP2098599A1 (en) * 2008-03-05 2009-09-09 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Composition comprising an oligonucleotide mixture for the detection of contaminations in cell cultures
US9834815B2 (en) * 2009-03-25 2017-12-05 Life Technologies Corporation Discriminatory positive/extraction control DNA
EP2445936A1 (en) 2009-06-26 2012-05-02 Regeneron Pharmaceuticals, Inc. Readily isolated bispecific antibodies with native immunoglobulin format
JP5765790B2 (ja) 2010-10-21 2015-08-19 ドイッチェス・クレープスフォルシュングスツェントルムＤｅｕｔｓｃｈｅｓ Ｋｒｅｂｓｆｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ ラットパルボウイルスｈ−１ｐｖのそのカプシドの遺伝子操作による癌細胞への再標的化
AU2012221740B2 (en) * 2011-02-25 2016-11-17 Novartis Ag Exogenous internal positive control
CN102206713B (zh) * 2011-04-06 2013-01-02 浙江大学 三重荧光定量rt-pcr检测试剂盒及用途
GB201203568D0 (en) * 2012-02-29 2012-04-11 Vela Operations Pte Ltd Real time PCR detection of streptococcus
HU230463B1 (hu) 2012-07-02 2016-07-28 Ud-Genomed Medical Genomic Technologies Kft. Kontroll rendszer immunprecipitációs vizsgálatokhoz
WO2014055515A1 (en) * 2012-10-02 2014-04-10 Neurophage Pharmaceuticals, Inc. Use of p3 of bacteriophage fusion proteins as amyloid binding agents
GB2525024A (en) * 2014-04-10 2015-10-14 Vela Operations Pte Ltd Universal controls for sequencing assays
TW202336236A (zh) 2015-03-27 2023-09-16 美商再生元醫藥公司 偵測生物污染物之組成物及方法

Also Published As

Publication number Publication date
JP7385623B2 (ja) 2023-11-22
AU2016243498A2 (en) 2018-04-19
IL254731A0 (en) 2017-11-30
JP2023184743A (ja) 2023-12-28
US10669594B2 (en) 2020-06-02
PL3274469T3 (pl) 2020-10-05
CN107960108A (zh) 2018-04-24
US20230295747A1 (en) 2023-09-21
AR104110A1 (es) 2017-06-28
EP3699298B1 (en) 2024-04-24
EA201792155A1 (ru) 2018-04-30
CA2980915A1 (en) 2016-10-06
TWI804917B (zh) 2023-06-11
KR20180026661A (ko) 2018-03-13
ES2804845T3 (es) 2021-02-09
CN114875175A (zh) 2022-08-09
CA2980915C (en) 2024-02-27
CA3226784A1 (en) 2016-10-06
ZA201706797B (en) 2020-01-29
IL254731B (en) 2021-04-29
EA037740B1 (ru) 2021-05-17
BR112017020582A2 (pt) 2018-07-17
TW202336236A (zh) 2023-09-16
EP3274469A1 (en) 2018-01-31
TW201706413A (zh) 2017-02-16
IL289447A (en) 2022-02-01
DK3274469T3 (da) 2020-06-15
AU2016243498A1 (en) 2017-10-26
IL281579A (en) 2021-05-31
IL302434A (en) 2023-06-01
JP2020103306A (ja) 2020-07-09
SG11201707690QA (en) 2017-10-30
KR102662675B1 (ko) 2024-05-03
US20200248278A1 (en) 2020-08-06
TW202140801A (zh) 2021-11-01
SG10202006108RA (en) 2020-08-28
PT3274469T (pt) 2020-05-29
IL281579B (en) 2022-02-01
EA202190319A1 (ru) 2021-09-30
JP6894026B2 (ja) 2021-06-23
TWI735433B (zh) 2021-08-11
MX2017012437A (es) 2018-06-19
AU2022246398A1 (en) 2022-11-03
US11549154B2 (en) 2023-01-10
JP2021121226A (ja) 2021-08-26
AU2016243498B2 (en) 2022-07-07
EP4361290A2 (en) 2024-05-01
JP2018509174A (ja) 2018-04-05
KR20240063188A (ko) 2024-05-09
WO2016160572A1 (en) 2016-10-06
ZA201806101B (en) 2020-12-23
CN107960108B (zh) 2022-03-08
AR119878A2 (es) 2022-01-19
US20160281182A1 (en) 2016-09-29
EP3274469B1 (en) 2020-04-29
JP6670847B2 (ja) 2020-03-25
EP3699298A1 (en) 2020-08-26

Similar Documents

Publication Publication Date Title
MX2021007667A (es) Composiciones y metodos para detectar un contaminante biologico.
PH12017501967A1 (en) Maize plant dbn9936 and method for use in detecting nucleic acid sequence thereof
MX2017009766A (es) Detección de nanoporo de polinucleótidos blanco de fondo de muestra.
MX2017005159A (es) Composiciones y metodos para detectar un virus de rna.
EA201790716A1 (ru) Использование панелей мутантных генов fgfr для выявления онкологических пациентов, которые будут поддаваться лечению ингибитором fgfr
MX2020010692A (es) Metodos y sistemas para la deteccion rapida de microorganismos con el uso de bacteriofago recombinante.
MX2022014633A (es) Metodos para detectar norovirus.
SG10201903822XA (en) Method for the enrichment of circulating tumor dna
MX2014000920A (es) Metodo para evaluar la integridad de la pared celular bacteriana.
MX2015001961A (es) Metodos y sistemas para ensayos.
MX2018015213A (es) Secuencia de acido nucleico para detectar la existencia del evento de soya transgenica dbn9004 en una muestra biologica, equipo que contiene la misma y metodo de deteccion para la misma.
AU2017248682A1 (en) Method for detecting and/or characterising tumour cells and associated apparatus
MX2021009528A (es) Prueba de diagnostico basada en fragmento de rgma.
GB2542576A (en) Method and kit of detecting the absence of micro-oranisms
MX2019007894A (es) Composiciones y metodos para detectar el adn tumoral circulante.
PH12017501957A1 (en) Herbicide-tolerant maize plant dbn9858, and nucleotide sequence and method for detecting same
EP3208333A4 (en) Method for detecting and quantifying target nucleic acid in test sample using novel positive control nucleic acid
MX2017006898A (es) Amplificacion y deteccion de acidos nucleicos en una muestra biologica.
MX2017003832A (es) Metodo para la prediccion de sensibilidad a un tratamiento con un inhibidor de egfr.
MX2016013877A (es) Composiciones y metodos para mejorar y/o predecir la amplificacion de adn.
MX2016017136A (es) Composiciones y metodos para detectar pegivirus 2 de humano (hpgv-2).
EP3878979A3 (en) Molecular detection of enterovirus and parechovirus
MX2018006146A (es) Modificación de diana para seguimiento y detección.
WO2015157624A3 (en) A novel isoform of anaplastic lymphoma kinase and its uses
CA2863358A1 (en) Methods and compositions for determining virus susceptibility to non-nucleoside reverse transcriptase inhibitors